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Abstract 
Objective Thymic function declines exponentially with age. Impaired thymic 
function has been associated with autoimmune disease in adults but has never been 
formally assessed in childhood autoimmunity. We therefore determined thymic 
function in children with the autoimmune disease Juvenile Idiopathic Arthritis (JIA). 
Methods We measured thymic function in 70 children and young adults with JIA 
(age range 2.1 – 30.8 (median 10.4)) and 110 healthy age matched controls using four 
independent assays. We quantified T-cell receptor excision circles 
(WBLogTREC/ml), the proportion of CD4
+ 
CD45RA
+
CD31
+ 
T-cells (representing 
recent thymic emigrants - %RTE) and measured intra-thymic proliferation by 
calculating the αTREC/βTREC ratio. Lastly, regulatory T-cells (TReg) of thymic 
origin (CD4
+
FOXP3
+
) were quantified in peripheral blood to assess the ability of the 
thymus in JIA to generate this T-cell subset. 
Results Thymic function was equivalent by all four parameters in JIA when 
compared with our control population. Furthermore, there was no consistent effect of 
JIA subtype on thymic function, although intra-thymic proliferation was higher in the 
small RF
+
polyarticular group. There were no significant effects of disease modifying 
anti-rheumatic drugs (DMARDs) or oral corticosteroids on thymic function, although 
those with the worst prognostic ILAR subtypes were also those most likely to be on a 
DMARD. 
Conclusions We demonstrate that children and young adults with JIA, unlike adults 
with autoimmune diseases, have thymic function that is comparable with healthy 
controls. The varied pathologies represented by the term ‘JIA’ suggest this 
observation may not be disease specific and raises interesting questions about the 
aetiology of thymic impairment in adult autoimmunity.
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Introduction 
The thymus plays a critical role in the development of normal immune tolerance (1). 
As well as negatively selecting potentially autoreactive T-cells, it also positively 
selects the naturally occurring regulatory T-cell subset (TReg) (CD4
+
FOXP3
+
) (2). 
Cross-sectional studies have demonstrated impaired thymic function in several adult 
autoimmune diseases (3-6). It remains unclear whether the thymic defect is primary or 
secondary, although single gene defects affecting thymic integrity can predispose to 
autoimmunity (7, 8). In contrast to adults, thymic function has not been formally 
quantified in childhood autoimmunity such as JIA.  
The normal thymus is largest in childhood and is well known to decline in size and 
function with increasing age (9). Whilst not normally of apparent consequence, this 
decline becomes important under circumstances where the T-cell pool is depleted, 
such as in HIV-AIDS or during lympho-ablative treatments such as bone marrow 
transplant (BMT) or stem cell transplantation (SCT). This [normal] decline in thymic 
function with aging is thought to explain the slower and often less complete T-cell 
reconstitution following SCT in adults when compared with that in children (10, 11). 
JIA describes a heterogeneous group of diseases (12) ranging in severity from severe 
polyarticular disease sometimes associated with systemic features, to more benign 
oligoarticular disease. The more severe JIA subtypes have a poor prognosis with lack 
of response to intense immunosuppression in some cases (13, 14). Autologous SCT 
has recently been shown to induce prolonged, drug free remission in a proportion of 
such refractory patients (15). 
Measuring thymic function in humans is complicated by the lack of a specific 
phenotype for recent thymic emigrants (RTE), although the surface profile 
CD4
+
CD45RA
+
CD31
+ 
has been proposed as a potential marker (16).  Rearrangement 
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of the T-cell receptor alpha chain gene results in the formation of an episome of DNA 
called a ‘T cell receptor excision circle’ (TREC) (17). TREC are present only in 
thymically-derived T-cells and do not divide with cellular mitosis. When quantified 
per millilitre of whole blood, TREC are widely accepted to be the optimal 
measurement of thymic function (18).  
In the current study we compare thymic function in children with JIA and healthy 
controls. By measuring TRECs, the proportion of CD4
+
CD45RA
+
CD31
+ 
T-cells and 
TReg in peripheral blood, and intra-thymic T-cell development using a novel assay, we 
demonstrate that thymic function is not compromised in JIA. 
 
Patients and Methods 
Study subjects 
Following ethical approval and informed consent from the child and/or a parent or 
guardian, 9ml blood samples were obtained from healthy control children undergoing 
simple surgical procedures. Samples from young adults were donated by healthy 
volunteers. Study subjects were consecutive attendees at the Newcastle Regional 
Paediatric Rheumatology Service in Newcastle. All were given a diagnosis of JIA 
classified according to the ILAR classification by a consultant Paediatric 
Rheumatologist (12). Samples from older patients were obtained at adolescent and 
young adult rheumatology clinics. Blood was collected into Vacuette EDTA K3 tubes 
(Greiner Bio-one, Austria). 
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DNA extraction  
DNA was extracted from 300l whole blood using the Wizard Genomic DNA 
extraction kit ® (Promega) and stored at 4C. Sample purity and quantity was 
determined by spectrophotometry (Nanodrop® ND-100).  
 
TREC Quantification 
We have developed a method quantifying TREC/ml in DNA extracted from 300l 
whole blood (manuscript submitted). Briefly, WBLogTREC/ml is determined from a 
simultaneously amplified standard curve (range 10
7
- 10
1 
TREC molecules) using 
quantitative real time PCR (RQ-PCR), ABI Prism 7900HT Sequence Detector System 
and SDS2.2 software (Applied Biosystems, Warrington, UK).  
25l reactions contained primers CACATCCCTTTCAACCATGCT and 
GCCAGCTGCAGGGTTTAGG both at 700nM, 150nM Taqman hydrolysis probe (6-
FAM-ACACCTCTGGTTTTTGTAAAGGTGCCCACT-TAMRA), 12.5l 
JumpStart
™
 Taq ReadyMix (SIGMA) and 200ng DNA. Thermal cycling conditions 
were 50C for 2 minutes then 95C for 10 minutes, then 40 cycles of 95C for 15 
seconds and 60C for 1 minute. Experimental samples were run in duplicate and 
averaged.  
 
Quantification of intra-thymic proliferation  
Intra-thymic proliferation was measured using a modified version (to allow for use 
with SYBR Green) of the method published by Dion et al (19).  Ten TCR chain 
DJ  rearrangements (TREC) and the TCR chain recJ rearrangement 
(TREC) were quantified in separate, nested PCRs. A duplex first round reaction with 
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primers for individual TREC and genomic CD3 was followed by individual RQ-
PCRs. The CD3 copy number multiplied by 0.5 (since each cell contains two copies) 
allowed TREC frequency to be reported per 105 cells. 
First round 25l PCR reactions contained 1x High Fidelity PCR buffer (Invitrogen), 
0.2mM each of dNTPs (Invitrogen), 1.5mM MgCl2 (Invitrogen), 1U Platinum Taq 
High Fidelity (Invitrogen), 500nM of both primers (Sigma Genosys) and 150ng target 
DNA. Initial denaturation was at 95C for ten minutes followed by 22 cycles of 95C 
for 30s and 72C for 30seconds. Second round, 25l reactions contained 2X 
SybrGreen® PCR Master Mix (TAKARA), 400nM of each primer (SIGMA Genosys) 
and 10l template. Thermal cycling conditions were 95C for 10 seconds followed by 
40 cycles of 95C for 5 seconds and 60C for 60 seconds.  
 
Surface staining of PBMC for quantification of recent thymic emigrants 
70l of whole blood was incubated in the dark at room temperature for 15 minutes, 
with combinations of antibodies to surface antigens: CD31-PE, CD45RA-FITC 
(Serotec, Oxford UK) and CD4-PE-Cy5 (Beckton Dickinson). Stained samples were 
incubated with 1X FACS Lyse Solution ® (Beckton Dickinson) for 10 minutes and 
washed twice.  
 
Isolation of PBMC from whole blood and intracellular cell staining 
PBMC were isolated according to a standard, sucrose density gradient 
(Lymphoprep®) protocol and cryopreserved in 10% DMSO in FCS at -80C until use. 
Thawed cells were surface stained with CD4
+
-FITC and then FOXP3-APC antibody 
(eBiosciences,Wembly, UK) according to the manufacturer’s instructions. Flow 
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cytometry was performed using a FACScan ™ and data analysed using 
FloJOv6.1.2®. Sample identities were blinded to the assessor.  
 
Statistical Analysis 
Statistical analyses were performed using SPSS© 11
th
 edition software. Values for 
WBLogTREC/ml were initially log transformed to allow parameteric testing. 
Population distributions were tested for normality with a one sample Kolmogorov-
Smirnov test. Correlations for normally distributed data were tested for significance 
using Pearson’s correlation coefficient. Differences between groups were assessed by 
analysis of covariance (ANCOVA) where other covariates were present, unless 
otherwise stated. Bonferroni corrections were applied to correct for multiple 
comparisons. Results were considered significant when p  0.05. 
 
Results 
Thymic function declines with age throughout childhood and does not differ between 
JIA patients and healthy controls 
WBLogTREC/ml was quantified in 70 patients with JIA and 110 healthy controls 
(HC). Table 1 describes the cohort. One additional patient had DiGeorge Syndrome 
(chromosome 22q11 deletion associated syndrome with thymic hypoplasia / aplasia) 
and a co-existing inflammatory arthritis. Figure 1A shows that there was no 
significant difference in thymic function between the groups after adjusting for age 
and gender (see below). Negative correlations with age were detected for both groups 
(p < 0.01). The patient with DiGeorge Syndrome had markedly deficient thymic 
function as evidenced by a 1.5Log deficit in WBLogTREC/ml when compared with 
Lorenzi & Morgan 9 
age matched controls. There was no difference in thymic function when ILAR JIA 
subtypes were compared (Figure 2A). 
 
  N 
Age / yrs  - median  
(range) 
Male  
(%) 
DMARD 
any (%) 
MTX 
(%) 
Biologic* 
(%) 
Oral steroid  
(%) 
No 
DMARD** 
 
Systemic Onset 8 10.52 (3.51-15.12) 6 (75) 7 (88) 5 (63) 3 (38) 3 (38) 1 (12.5) 
 
Polyarticular RF+ 10 9.92 (4.11-17.85) 3 (30) 7 (70) 6 (60) 1 (10) 3 (38) 2 (20) 
 
Polyarticular RF- 12 12.59 (2.85-15.13) 2 (16) 7 (58) 6 (50) 2 (17) 3 (38) 5 (41) 
 
Persistent 
oligoarticular 27 9.16 (2.06-28.74) 7 (27) 2 (7) 2 (7) 0 0 25 (93) 
 
Extended 
oligoarticular 7 10.3 (4.03-17.96) 2 (28) 4 (57) 1 (14) 3 (43) 0 3 (43) 
 
Psoriatic 4 19.3 (14.36-30.78) 3 (75) 2 (50) 1 (25) 1 (25) 1 (25) 2 (50) 
 
Enthesitis 2 14.25 (12.8-15.69) 1 (50) 2 (100) 2 (100) 0 1 (50) 0 
 
* Includes anti TNFα agents and anti IL-1. **Includes those taking only NSAIDs or relying only on 
local joint injections for disease control. RF – rheumatoid factor; DMARD disease modifying anti- 
rheumatic drug; MTX – methotrexate. 
 
Table 1 – Patient characteristics according to ILAR subtype 
 
The proportion of CD4
+
CD45RA
+
CD31
+
 declines with age in HC and JIA  
CD4
+
CD45RA
+
CD31
+
 T-cells are TREC rich and have been proposed as the 
phenotype of RTE in humans (16). The proportion of T-cells with this phenotype 
(%RTE) declined with age in JIA (n = 50) and HC (n = 77) (Figure 1B) but there was 
no significant difference in age adjusted mean %RTE. 
Since both WBLogTREC/ml and %CD4
+
CD45RA
+
CD31
+
 T-cells have been 
proposed as markers of thymic function there should be a strong positive correlation 
between them, independent of disease status. Although the relationship was strong in 
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HC (r = 0.71; p < 0.01), it was less robust in JIA (0.45; p <0.01). There was no effect 
of ILAR subtype on %RTE (Figure 2B). 
In our patient with DiGeorge Syndrome, the %RTE was normal despite a significantly 
reduced WBLogTREC/ml value (Figure 1B), suggesting that CD4
+
CD45RA
+
CD31
+
 
T-cells may be capable of self renewal in the absence of thymic replenishment. 
 
Gender differences in thymic function are preserved in children with JIA  
In both mice and adult humans, females have a larger thymic output (as determined by 
TREC quantification and histological analysis of thymic volume) than age matched 
males (20, 21). Using the two assays described above, we confirmed higher age-
adjusted thymic output in females, both in HC and JIA patients (Figure 1 C & D). The 
age-adjusted mean WBLogTREC/ml value for HC females (n = 51) was 5.039 and for 
males (n = 59) 4.985 (p = 0.002); in JIA the comparable figures were 5.004 (n = 46) 
and 4.826 (n = 24), (p = 0.003).  
Using %RTE a gender difference was again detected in HC (age adjusted mean 
%RTE in females (n = 36) 52.9%, males (n = 41) 45.6% (p = 0.001) but not in JIA 
group (data not shown).  
 
Effect of immunosuppressant therapy on thymic function in JIA 
Corticosteroids and some immunosuppressive treatments have been considered to 
inhibit thymic function (22-24) and we therefore sought an effect in JIA. It should be 
noted that the majority of children taking DMARDs or oral corticosteroids had more 
severe disease, falling into the systemic-onset, polyarticular and extended 
oligoarticular subtypes (see Table 1).  However, when patients receiving these drugs 
were compared with those not receiving them and with healthy controls using 
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WBLogTREC/ml, no evidence of a significant effect of DMARDs (when considered 
collectively (n = 31)) (4.874 v 4.933 v. 4.985) (Figure 3A) or corticosteroids ( 
DMARD) (n = 11) (4.818 v. 4.924 v. 4.985) was found (data not shown). There was, 
however, a trend toward lower WBLogTREC/ml values in JIA patients on a DMARD 
(p = 0.061) and those taking steroid ( DMARD) (p = 0.07) when compared with 
healthy controls. There was no effect of taking MTX on WBLogTREC/ml values 
(4.887) when compared with those not on MTX (4.917) and with HC (4.985) (p = n.s) 
although some patients not on MTX were taking an alternative DMARD (primarily 
anti TNF) (n = 8). Other treatment groups contained too few patients to exclude an 
independent effect. In contrast, after adjustment for age and gender, %RTE was 
significantly higher in patients on oral corticosteroid (n = 8; 58.3%) than in those not 
on oral corticosteroid (n = 40; 47.0%; p = 0.013) and the comparison with HC (n = 
77) approached significance (49.8%; p = 0.067). There was no difference between 
those not on oral corticosteroid and HC.  There was no significant effect of DMARD 
use (Figure 3B) or MTX specifically on %RTE.  
 
Intra-thymic proliferation in JIA 
When the TCR chain gene rearranges, the locus encoding the TCR chain is excised 
in a conserved rearrangement resulting in the formation of a TREC that can be 
identified in approximately 70% of emerging thymocytes. This rearrangement is the 
basis of most standard TREC assays, including our own WBLogTREC/ml assay (17). 
When the TCR chain gene is rearranged, no single rearrangement occurs but there 
are only 13 potential DJ gene rearrangements (25). Dion et al devised an assay 
that quantifies 10 of these 13 TREC generating rearrangements, the sum of which 
provides an estimate of the frequency of T-cells in peripheral blood that have 
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rearranged their TCR chain gene (TREC) (19). TCR chain rearrangement occurs 
after TCR chain rearrangement. Between these events a phase of thymocyte 
proliferation expands thymocytes with a rearranged TCR chain, providing a 
substrate for the subsequent generation of TCR diversity through  chain/ chain 
pairing. The ratio between the numbers of T-cells containing detectable TCR and 
TCR chain rearrangements (TREC:TREC) therefore gives an indication of the 
number of divisions, which is a measure of intra-thymic proliferation and overall 
thymic function.  
We determined intra thymic function in JIA and HC. No difference was found when 
19 children with JIA were compared with 19 healthy controls and there was also no 
detectable effect of gender (data not shown). There were insufficient samples to seek 
an effect of corticosteroid or DMARDs. The effect of ILAR sub classification was 
assessed. There were no significant differences between the groups after post hoc 
testing with the exception of all comparisons with the polyarticular RF
+
 group (n = 3) 
which, (after the two groups where n = 1 were excluded), achieved statistical 
significance  - Figure 4A.  The true significance of this result is difficult to assess 
because of small patient numbers and was lost when we combined together the poor 
prognosis subtypes of systemic onset, polyarticular, and extended oligoarticular JIA 
(‘non-oligoarticular’, n = 9) and compared with persistent oligoarticular JIA  
(‘oligoarticular’ n = 11), a classification previously used (26) (Figure 4B).  
In the patient with DiGeorge Syndrome, the TREC:TREC ratio was 57 in 
comparison with the HC group median (352) and the JIA group median (628), 
reflecting the impaired structural environment of the DiGeorge thymus and its 
reduced capacity for thymocyte expansion. The TREC value in this patient was 
comparable to JIA values 1.58 v. 5.38 (range 0.53 – 17.41) whereas the TREC value 
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was significantly reduced, 91 v. 3002 (range 851 – 5065). This implies that thymocyte 
proliferation is impaired in DiGeorge Syndrome in comparison with HC and children 
with JIA. 
  
Thymus derived TReg are more frequent in persistent oligoarticular JIA   
Lastly, we quantified the proportion of CD4
+
 T-cells with the regulatory phenotype 
CD4
+
FOXP3
+
 (TReg). There was no detectable difference overall between JIA patients 
and HC. When individual ILAR subtypes were compared there was a weak but 
significant difference between the systemic and persistent oligoarticular disease 
patients (p = 0.031) in a post hoc analysis, although sample sizes were again small - 
Table 2. To strengthen our analysis by increasing group numbers, patients with ‘non-
oligoarticular’ disease (as above) were compared with persistent oligoarticular 
patients. We found a significant increase in the proportion of TReg in the oligoarticular 
group (8.19 % v. 6.481%; p = 0.044 - Tukey HSD post hoc analysis), consistent with 
other reports. Unlike those reports however, there was no difference from HC. There 
was no effect of gender, age or DMARD use, although MTX use was more common 
in non-oligoarticular JIA (see Table 1), potentially confounding the difference 
between disease subtypes.  
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 n %CD4
+
FOXP3
+
 (mean)  95%CI 
 
Non oligoarticular
§
 
 
27 6.48 5.54 -7.43 
      Systemic*  4 4.79 2.31 - 7.27 
      Polyarticular RF+ 7 7.32 5.44 - 9.20  
      Polyarticular RF- 10 6.57 5.00 - 8.14 
      Extended Oligoarticular 6 6.49 4.45 - 8.51 
 
   
Persistent Oligoarticular
§,
* 22 8.19 7.00 – 9.39 
 
   
§
Healthy controls 33 6.91 6.05 - 7.78 
 
Table 2 Mean values for %CD4
+
FOXP3
+
 and 95% CI for the ‘non-oligarticular’ group (comprising 
systemic, polyarticular RF
+
 and RF
-
 and extended oligoarticular ILAR categories), the persistent 
oligoarticular group and a healthy control group.  
§
TReg were significantly higher in the persistent oligoarticular group when compared with the non 
oligoarticular group (p = 0.044) but not healthy controls (p = 0.720). 
When individual ILAR subtypes were compared there was a significant difference between the 
systemic and persistent oligoarticular ILAR subtypes (p = 0.031) - Games-Howell post-hoc test 
analysis (which accounts for the differing group sizes).  
 
Discussion  
Our data demonstrate that, in children with JIA, thymic function is comparable with 
that of healthy control children. This conclusion is strengthened by our analysis of 
multiple aspects of thymic function, including intra-thymic proliferation and ‘down-
stream’ effects on recent thymic emigrants and TReg. Consistent with previous reports 
we have demonstrated greater thymic function in females (27) and an age-associated 
decline in healthy controls (28), findings that persist in JIA. In a single patient with 
inflammatory arthritis and co-existent DiGeorge syndrome we showed a dramatic 
reduction in thymic function, consistent with thymic hypo/aplasia and similar to the 
effect of partial thymectomy during paediatric cardiac surgery (29).  Although we 
have previously confirmed that consecutive recruitment of patients from our clinic 
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population provides a group of patients with a typical case mix (30)  (Table 1), the 
short recruitment period (4 months) may have biased our population toward those 
with more severe disease (since they are more likely to attend hospital). 
 
When data were analysed according to ILAR disease subtype, a minority of 
comparisons reached statistical significance or demonstrated a trend in that direction. 
For example, there was a trend toward reduced thymic function for those on a 
DMARD (although since disease group and DMARD use co-segregate, this analysis 
is confounded by ILAR subtype), and steroid use was associated with an increase in 
the %RTE. The TREC:TREC ratio was increased in the ILAR polyarticular RF+ 
group, whilst the persistent oligoarticular group had a significantly higher proportion 
of TReg than the ILAR systemic disease group, consistent with previous reports. These 
isolated observations should be interpreted with caution due to the small group 
numbers and require further analysis in a larger study in order to determine their true 
significance. 
 
T-cells with the phenotype CD4
+
CD45RA
+
CD31
+
 have significantly higher TREC 
content per cell than unselected CD4
+
 T-cells (16) confirming this subset is enriched 
for true thymic emigrants. Furthermore, CD4
+
CD45RA
+
CD31
+
 T-cell telomeres are 
longer and telomerase activity higher than in CD4
+
CD45RO
+
CD31
+
 T-cells, 
suggesting a limited replicative history (31). This phenotype has been used to monitor 
thymic function longitudinally (32-34) and although inter-individual variation is high, 
values are stable longitudinally ((34) and AR Lorenzi & JD Isaacs unpublished 
results). Thus, it was interesting to note that, despite a ~ 1.5Log deficit in 
WBLogTREC/ml in a patient with DiGeorge Syndrome, the proportion of 
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CD4
+
CD45RA
+
CD31
+
 T-cells was age appropriate. Furthermore, WBLogTREC/ml 
and %RTE did not always correlate well, particularly in disease, (lending support to 
the recent observation that CD4
+
CD45RA
+
CD31
+
 T-cells can in part be maintained 
by peripheral homeostasis (35)) and thus may represent a less useful measure of 
thymic function in this setting. Naïve T-cells proliferate excessively in RA patients, 
possibly under cytokine stimulation (36). A similar phenomenon in JIA would 
weaken the correlation between CD4
+
CD45RA
+
CD31
+
 T-cells and WBLogTREC/ml, 
as we have shown here. 
 
Regardless of its indication, adults fare less well than children following ASCT (37). 
In part this reflects an inverse relationship between age and CD4
+
 T-cell 
reconstitution (38, 39) but, in autoimmunity, disease-related thymic compromise may 
exacerbate the distinction. For example, RA patients remain lymphodepleted for years 
following ASCT (40) but disease usually relapses rapidly despite persisting 
lymphopenia. In contrast, JIA patients reconstitute more rapidly and, moreover, 
thymically-derived TReg may contribute to long-term remission of symptoms (41). 
Thus, measures aimed at reversing age-associated thymic atrophy (currently in 
clinical trial (42, 43) could significantly improve the outcome of ASCT in adults with 
autoimmune diseases. 
 
The normal thymus produces T cells that are self-tolerant with a polyclonal TCR 
repertoire. Age-related thymic involution results in a proportionally greater decline in 
thymocytes with rearranged TCR genes than with TCR chain genes (19), with 
potential implications for repertoire diversity (44) and therefore the maintenance of 
self tolerance, responses to neoantigens and tumour surveillance (45). We determined 
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a ratio that reflected the number of cellular divisions between these two events.  The 
similarity between patients (when collectively considered) and controls suggests this 
step in thymocyte development is intact in JIA. When individually considered 
however, there was a significant increase in the ratio for the polyarticular RF
+
 
patients. A single extreme value contributes to this effect but the remaining two 
individual values were also greater than for all other subtypes (Figure 4A) a 
consequence of both low TREC and high TREC values (data not shown). The 
significant contribution of the TREC value to the ratio and the variance of this value 
in both JIA and HCs (Figure 1) should also be noted and duplication of our results is 
required before further conclusions about this difference can be drawn. If confirmed, 
however, this result would suggest enhanced intra-thymic proliferation in the JIA 
subtype that most closely resembles adult RA, in which there is evidence of impaired 
thymic function (3). TCR diversity and TREC are positively correlated (46) 
suggesting that the TCR repertoire in JIA is also likely to be maintained.  
 
De Kleer et al distinguished two subsets of TReg in JIA peripheral blood following 
ASCT (41). Expansion of mature, non depleted or grafted TReg in the lymphopenic 
environment was followed 6-8 months later by the appearance of TReg of recent 
thymic origin (which may have greater suppressive function than memory CD45RO
+
 
TReg (47)), together replenishing the depleted pre-transplant TReg pool (41). Although 
we did not distinguish TReg subsets, we found a higher proportion of TReg in persistent 
oligoarticular disease than in non-oligoarticular disease although we could not 
confirm a difference between either group and HC, possibly reflecting our use of 
FOXP3 to quantify TReg, rather than CD25
bright
 (41). We have previously shown that 
adults with self-limiting reactive arthritis have a higher proportion of TReg than adults 
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with RA (48) and murine studies have demonstrated that Foxp3
+
 T-cells protect 
against autoimmune disease and inflammation in vivo (49). Collectively, these data 
suggest that control of inflammatory disease may be associated with this subset of T-
cells. Indeed, all 4 systemic JIA patients studied here had a very low proportion of 
TReg in peripheral blood. However, their otherwise normal thymic function suggests 
that their TReg deficit may reflect a failure of peripheral TReg homeostasis in 
progressive, chronic disease.  
 
In conclusion, using a variety of measurements we have demonstrated age-appropriate 
thymic function in JIA patients. We found no clear influence of therapy on thymic 
function although DMARD use was more common in poor prognosis JIA patients and 
was associated with trends toward lower WBLogTREC/ml values. We also found 
similar TReg values in HC and JIA although JIA patients of better prognosis subtype 
had higher values.  Our findings differ from those in adult patients with autoimmune 
disease, in whom thymic dysfunction has been implicated as a possible aetiological 
factor (3-6).  
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Figure 1 - Thymic function is not significantly different in children with JIA (open 
circles, dashed regression line) and healthy controls (HC) (filled circles- solid 
regression line) when quantified using WBLogTREC/ml (A) and by the proportion of 
T-cells with the phenotype CD4
+
CD31
+
CD45RA
+
 (%RTE) (B). WBLogTREC/ml 
was significantly negatively correlated with age (r = -0.762; p<0.001 for controls and 
r = 0.625; p<0.001 in JIA) as was %RTE (r = -0.656; p<0.001 and r = 0.491; p<0.001 
respectively). In a single patient with co-existent DiGeorge Syndrome (grey triangle 
with dashed circle surround), TREC levels were markedly reduced but %RTE was age 
appropriate.  
In both HC (C) and JIA (D), females (open circles, dashed regression lines) have 
greater thymic function than males (closed squares, solid regression line) using 
WBLogTREC/ml (p = 0.002 and p = 0.003 respectively). 
 
Figure 2 - Thymic function does not significantly differ between ILAR JIA subtypes 
when measured using either WBLogTREC/ml (A) or %RTE – (p = n.s) (B). Bars 
represent age adjusted group means  SEM. Groups were compared using ANCOVA 
with age as a covariate and multiple comparisons corrected for by performing a 
Bonferroni correction.  
(PolyRF – polyarticular RF positive and negative respectively, PsA – psoriatic, Enth – 
enthesitis associated, Ext oligo – extended oligoarticular, Persis oligo – persistent 
oligoarticular).  
 
Figure 3 - There was no significant effect on thymic function when measured using 
WBLogTREC/ml (A) or %RTE (B) of being on a DMARD. Bars represent age and 
gender adjusted group means  SEM. Groups were compared by ANCOVA with a 
Bonferroni correction to adjust for multiple comparisons. Patients not on a DMARD 
were more likely to have persistent oligoarticular disease than those taking one – see 
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Table 1. There was a trend toward lower WBLogTREC/ml values in those taking a 
DMARD (p = 0.061) when compared with healthy controls (HC). *Includes those 
taking only NSAIDs or relying only on local joint injections for disease control. 
**DMARDs include anti-TNFα agents and IL-1ra.  
 
Figure 4A - The TREC:TREC ratio (y axis) was compared between ILAR 
subtypes using ANCOVA with Bonferroni correction for multiple comparisons with 
age and gender as covariates because of their effect on the TREC value. When the 
two subsets where n = 1 were excluded, the comparisons between the polyarticular 
RF
+
 group and the reminder were statistically significant (p<0.05) - although caution 
should be applied to the interpretation of this result given the small group numbers. 
(Sys – systemic (n =3); PRF+ & PRF- - polyarticular RF+ / PRF- (n = 3 both groups); 
PsA – psoriatic (n =1); ExO– extended oligoarticular (n = 1); PerO - persistent 
oligoarticular (n = 8). 
(B) When grouped into persistent oligoarticular disease and non-oligoarticular disease 
(see text) there were no significant differences between the groups. Boxes represent 
the inter-quartile ranges (IQR) and bars the group medians. Whiskers give the data 
range with ‘’ representing extreme values (> 3 IQR from the box end). 
 
